Bemnifosbuvir (AT-511) is a phosphoramidate prodrug of a 2-C-methylguanosine monophosphate analog, demonstrating potent anti-HCV activity in vitro. It is a research compound used in virology and antiviral drug discovery, with studies investigating its efficacy in both cell-based assays and animal models of hepatitis C infection.